Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer

Completed · Phase 3

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether mitoxantrone and prednisone are more effective with or without prinomastat in treating patients with metastatic prostate cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of mitoxantrone and prednisone with or without prinomastat in treating patients who have metastatic prostate cancer that has not responded to hormone therapy.

Key facts

Study ID

NCT00003343

Run by

Pfizer

People needed

525

Starts

1998-03-01

Last updated by the study team

2012-08-08

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Agouron Pharmaceuticals, Inc. — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.